There were no adverse situations or variations from baseline in serologic research and vital signals in any of your contributors. The cure's suffering-relieving results were being verified by way of common, twelve-week observe-ups, confirming the protection and usefulness of BTX-A on Persistent ON and suggesting that this method is an effective, no